Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federica Melle

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Therapeutic Advances in Hematology|April 2, 2014
The evolution of clonality testing in the diagnosis and monitoring of hematological malignanciesAnna Gazzola, Claudia Mannu, Maura Rossi, et al.
Haematologica|May 21, 2026
Site-specific biology of tongue base aggressive B-cell lymphomas revealed by molecular subtype classificationDavide Chizzoniti, Caterina Cecchetti, Federica Melle, et al.
Hematology Reports|December 27, 2024
Venetoclax Plus Intensified Chemoimmunotherapy as a Bridge to Allogeneic Stem Cell Transplantation in Richter Syndrome: Report of Two CasesEnrico Derenzini, Alessandro Cignetti, Valentina Tabanelli, et al.
Virchows Archiv : an International Journal of Pathology|August 2, 2023
Mediastinal large B cell lymphoma and surrounding gray areas: a report of the lymphoma workshop of the 20th meeting of the European Association for HaematopathologySarah E Gibson, Stefan Dojcinov, Snjezana Dotlic, et al.
Blood Advances|September 4, 2020
Antitumor activity of the dual BET and CBP/EP300 inhibitor NEO2734Filippo Spriano, Eugenio Gaudio, Luciano Cascione, et al.
Ejhaem|February 10, 2025
Immune Signatures Identify Patient Subsets Deriving Long-Term Benefit From First-Line Rituximab in Follicular LymphomaGinevra Lolli, Alessandro Davini, Valentina Tabanelli, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 28, 2019
Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specifiedMaria Antonella Laginestra, Luciano Cascione, Giovanna Motta, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 28, 2019
Correction: Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specifiedMaria Antonella Laginestra, Luciano Cascione, Giovanna Motta, et al.
Blood Advances|February 22, 2023
Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCLSaveria Mazzara, Laura Travaini, Francesca Botta, et al.
British Journal of Haematology|December 24, 2021
Prognostic impact of TP53 mutation in newly diagnosed diffuse large B-cell lymphoma patients treated in the FIL-DLCL04 trialAnnalisa Chiappella, Fary Diop, Claudio Agostinelli, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Therapeutic Advances in Hematology|April 2, 2014
The evolution of clonality testing in the diagnosis and monitoring of hematological malignanciesAnna Gazzola, Claudia Mannu, Maura Rossi, et al.
Haematologica|May 21, 2026
Site-specific biology of tongue base aggressive B-cell lymphomas revealed by molecular subtype classificationDavide Chizzoniti, Caterina Cecchetti, Federica Melle, et al.
Hematology Reports|December 27, 2024
Venetoclax Plus Intensified Chemoimmunotherapy as a Bridge to Allogeneic Stem Cell Transplantation in Richter Syndrome: Report of Two CasesEnrico Derenzini, Alessandro Cignetti, Valentina Tabanelli, et al.
Virchows Archiv : an International Journal of Pathology|August 2, 2023
Mediastinal large B cell lymphoma and surrounding gray areas: a report of the lymphoma workshop of the 20th meeting of the European Association for HaematopathologySarah E Gibson, Stefan Dojcinov, Snjezana Dotlic, et al.
Blood Advances|September 4, 2020
Antitumor activity of the dual BET and CBP/EP300 inhibitor NEO2734Filippo Spriano, Eugenio Gaudio, Luciano Cascione, et al.
Ejhaem|February 10, 2025
Immune Signatures Identify Patient Subsets Deriving Long-Term Benefit From First-Line Rituximab in Follicular LymphomaGinevra Lolli, Alessandro Davini, Valentina Tabanelli, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 28, 2019
Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specifiedMaria Antonella Laginestra, Luciano Cascione, Giovanna Motta, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 28, 2019
Correction: Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specifiedMaria Antonella Laginestra, Luciano Cascione, Giovanna Motta, et al.
Blood Advances|February 22, 2023
Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCLSaveria Mazzara, Laura Travaini, Francesca Botta, et al.
British Journal of Haematology|December 24, 2021
Prognostic impact of TP53 mutation in newly diagnosed diffuse large B-cell lymphoma patients treated in the FIL-DLCL04 trialAnnalisa Chiappella, Fary Diop, Claudio Agostinelli, et al.
Pageof 4